Demo data. These are fictitious sample companies used to preview GroWiser. The figures are not real and are not investment information.
Godavari Lifesciences Ltd
NSE: GODAVARILSBSE: 548248Pharma Formulations
₹883.50
▲ 4.70 (+0.53%)
Profit & Loss
- FY22: 3,432
- FY23: 3,639
- FY24: 4,368
- FY25: 5,224
- FY26: 6,244
- FY22: 636
- FY23: 608
- FY24: 758
- FY25: 965
- FY26: 1,038
- FY22: ₹20.06
- FY23: ₹19.17
- FY24: ₹23.90
- FY25: ₹30.45
- FY26: ₹32.74
| ₹ Cr | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue from operations | 3,432 | 3,639 | 4,368 | 5,224 | 6,244 |
| Operating expenses | 2,507 | 2,740 | 3,232 | 3,839 | 4,720 |
| Operating profit (EBITDA) | 925 | 899 | 1,135 | 1,385 | 1,524 |
| Other income | 23 | 44 | 25 | 74 | 64 |
| Depreciation | 94 | 133 | 145 | 167 | 204 |
| Interest | 6 | 0 | 6 | 5 | 0 |
| Profit before tax | 848 | 810 | 1,010 | 1,287 | 1,384 |
| Tax | 212 | 203 | 253 | 322 | 346 |
| Net profit | 636 | 608 | 758 | 965 | 1,038 |
| EPS (₹) | 20.06 | 19.17 | 23.90 | 30.45 | 32.74 |
| Dividend per share (₹) | 10.36 | 9.90 | 12.34 | 15.72 | 16.91 |
Figures in ₹ Cr unless marked per share (₹). Consolidated.
Showing 5 of 10 periods. Premium unlocks the full 10-year history. See Premium